Logo for Vera Therapeutics Inc

Vera Therapeutics Investor Relations Material

Latest events

Logo for Vera Therapeutics Inc

R&D Day 2024

Vera Therapeutics
Logo for Vera Therapeutics

Q1 2024

9 May, 2024
Logo for Vera Therapeutics

Q4 2023

20 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Vera Therapeutics Inc

Access all reports
Vera Therapeutics, Inc. is a clinical-stage biotechnology company engaged in developing and commercializing treatments aimed at serious immunological diseases. Their portfolio includes atacicept, a fusion protein undergoing clinical trials for immunoglobulin A nephropathy and Phase II trials for lupus nephritis. Another significant development in their pipeline is MAU868, a monoclonal antibody targeting the BK virus in transplant patients. The company is headquartered in Brisbane, California, and its shares are listed on the NASDAQ.